Kefeng Lei

682 total citations
20 papers, 364 citations indexed

About

Kefeng Lei is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kefeng Lei has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kefeng Lei's work include RNA modifications and cancer (3 papers), Peptidase Inhibition and Analysis (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Kefeng Lei is often cited by papers focused on RNA modifications and cancer (3 papers), Peptidase Inhibition and Analysis (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Kefeng Lei collaborates with scholars based in China, United States and Bangladesh. Kefeng Lei's co-authors include Liu Yang, Jiahui Wang, Qiuran Xu, Yufeng Wang, Zhikui Liu, Changwei Dou, Jian‐Feng Tu, Xin Liu, Hang-xing Bao and Lijie Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular Cancer.

In The Last Decade

Kefeng Lei

18 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kefeng Lei China 9 251 141 75 46 39 20 364
Hao-Rong Wu China 10 237 0.9× 149 1.1× 64 0.9× 36 0.8× 30 0.8× 20 328
Yannasittha Jiramongkol United Kingdom 8 261 1.0× 99 0.7× 59 0.8× 29 0.6× 52 1.3× 12 373
Shouru Zhang China 12 331 1.3× 139 1.0× 131 1.7× 64 1.4× 30 0.8× 18 439
Yitao Wang China 10 230 0.9× 95 0.7× 89 1.2× 46 1.0× 32 0.8× 11 330
Xianju Qin China 12 260 1.0× 163 1.2× 70 0.9× 39 0.8× 31 0.8× 21 401
Zhicheng Gong China 12 350 1.4× 136 1.0× 96 1.3× 66 1.4× 41 1.1× 26 490
Pengyu Jing China 11 309 1.2× 112 0.8× 94 1.3× 59 1.3× 34 0.9× 23 417

Countries citing papers authored by Kefeng Lei

Since Specialization
Citations

This map shows the geographic impact of Kefeng Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Lei more than expected).

Fields of papers citing papers by Kefeng Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefeng Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Lei. The network helps show where Kefeng Lei may publish in the future.

Co-authorship network of co-authors of Kefeng Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Kefeng Lei. A scholar is included among the top collaborators of Kefeng Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefeng Lei. Kefeng Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinjie, Xulong Chen, Ling Cui, et al.. (2025). Relationship between internal metal exposure and thyroid cancer incidence: a case-control study simultaneously validated by BKMR and WQS models. Food and Chemical Toxicology. 201. 115443–115443. 2 indexed citations
2.
Liu, Dongwei, et al.. (2024). SPECC1 as a pan-cancer biomarker: unraveling its role in drug sensitivity and resistance mechanisms. Discover Oncology. 15(1). 552–552.
3.
Liu, Yuhong, Chen Wang, Guochuang Chen, et al.. (2024). Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system. Cancer Letters. 597. 217043–217043. 1 indexed citations
4.
5.
Yang, Qiong, et al.. (2022). Autophagy-related prognostic signature for survival prediction of triple negative breast cancer. PeerJ. 10. e12878–e12878. 5 indexed citations
6.
7.
Wang, Yun, Qian Liang, Kefeng Lei, et al.. (2021). Targeting MEX3A attenuates metastasis of breast cancer via β-catenin signaling pathway inhibition. Cancer Letters. 521. 50–63. 14 indexed citations
8.
9.
Zheng, Yajuan, Guansheng Zhong, Kun Yu, Kefeng Lei, & Qiong Yang. (2020). Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer. Frontiers in Oncology. 10. 148–148. 11 indexed citations
10.
Lei, Kefeng, et al.. (2019). Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer. PLoS ONE. 14(5). e0215948–e0215948. 10 indexed citations
11.
Yang, Qiong, et al.. (2019). Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study. Advances in Therapy. 36(5). 1211–1220. 6 indexed citations
12.
Lei, Kefeng, Ran Sun, Lee H. Chen, et al.. (2018). Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells. Scientific Reports. 8(1). 12507–12507. 5 indexed citations
13.
Yang, Liu, Yang Guo, Xin Liu, et al.. (2018). The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4. Journal of Cancer. 9(15). 2693–2701. 24 indexed citations
14.
Xu, Qiuran, Jian‐Feng Tu, Changwei Dou, et al.. (2017). HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Molecular Cancer. 16(1). 178–178. 189 indexed citations
15.
Xie, Qiuping, Cheng Xiang, Gang Wang, Kefeng Lei, & Yong Wang. (2016). MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis. Journal of Zhejiang University SCIENCE B. 17(5). 361–366. 15 indexed citations
16.
Lei, Kefeng, Bingya Liu, Xiaolong Jin, et al.. (2012). Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer. Experimental and Therapeutic Medicine. 3(6). 993–998. 9 indexed citations
17.
Lei, Kefeng, et al.. (2012). [Interaction of SerpinB5 and MAFbx in gastric cancer cell and its action site].. PubMed. 15(2). 169–73. 1 indexed citations
18.
Lei, Kefeng, Bingya Liu, Xiaolong Jin, et al.. (2011). Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors. Experimental and Therapeutic Medicine. 3(1). 109–116. 13 indexed citations
19.
Lei, Kefeng, Yanfang Wang, Lu Wang, et al.. (2007). Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer. 7(1). 172–172. 45 indexed citations
20.
Ye, Qing‐Hai, et al.. (2006). [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].. PubMed. 28(6). 404–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao-Rong Wu Breakdown of academic impact, for papers by Yannasittha Jiramongkol Breakdown of academic impact, for papers by Shouru Zhang Breakdown of academic impact, for papers by Yitao Wang Breakdown of academic impact, for papers by Xianju Qin Breakdown of academic impact, for papers by Zhicheng Gong Breakdown of academic impact, for papers by Pengyu Jing
Rankless by CCL
2026